194 related articles for article (PubMed ID: 23188471)
1. Two newborn-onset patients of Upshaw-Schulman syndrome with distinct subsequent clinical courses.
Tanabe S; Yagi H; Kimura T; Isonishi A; Kato S; Yoshida Y; Hayakawa M; Matsumoto M; Ohtaki S; Takahashi Y; Fujimura Y
Int J Hematol; 2012 Dec; 96(6):789-97. PubMed ID: 23188471
[TBL] [Abstract][Full Text] [Related]
2. Upshaw-Schulman syndrome revisited: a concept of congenital thrombotic thrombocytopenic purpura.
Kinoshita S; Yoshioka A; Park YD; Ishizashi H; Konno M; Funato M; Matsui T; Titani K; Yagi H; Matsumoto M; Fujimura Y
Int J Hematol; 2001 Jul; 74(1):101-8. PubMed ID: 11530798
[TBL] [Abstract][Full Text] [Related]
3. Congenital thrombotic thrombocytopenic purpura caused by new compound heterozygous mutations of the ADAMTS13 gene.
Rank CU; Kremer Hovinga J; Taleghani MM; Lämmle B; Gøtze JP; Nielsen OJ
Eur J Haematol; 2014 Feb; 92(2):168-71. PubMed ID: 24033710
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy-induced thrombocytopenia and TTP, and the risk of fetal death, in Upshaw-Schulman syndrome: a series of 15 pregnancies in 9 genotyped patients.
Fujimura Y; Matsumoto M; Kokame K; Isonishi A; Soejima K; Akiyama N; Tomiyama J; Natori K; Kuranishi Y; Imamura Y; Inoue N; Higasa S; Seike M; Kozuka T; Hara M; Wada H; Murata M; Ikeda Y; Miyata T; George JN
Br J Haematol; 2009 Mar; 144(5):742-54. PubMed ID: 19055667
[TBL] [Abstract][Full Text] [Related]
5. Plasma of patients with Upshaw-Schulman syndrome, a congenital deficiency of von Willebrand factor-cleaving protease activity, enhances the aggregation of normal platelets under high shear stress.
Yagi H; Konno M; Kinoshita S; Matsumoto M; Ishizashi H; Matsui T; Titani K; Fujimura Y
Br J Haematol; 2001 Dec; 115(4):991-7. PubMed ID: 11843838
[TBL] [Abstract][Full Text] [Related]
6. [Genetic polymorphism of von Willebrand factor (VWF)-cleaving protease, ADAMTS13].
Kokame K
Brain Nerve; 2008 Nov; 60(11):1325-32. PubMed ID: 19069166
[TBL] [Abstract][Full Text] [Related]
7. [Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].
Kato S; Fujimura Y
Rinsho Byori; 2015 Oct; 63(10):1228-36. PubMed ID: 26897861
[TBL] [Abstract][Full Text] [Related]
8. Novel compound heterozygote mutations (H234Q/R1206X) of the ADAMTS13 gene in an adult patient with Upshaw-Schulman syndrome showing predominant episodes of repeated acute renal failure.
Shibagaki Y; Matsumoto M; Kokame K; Ohba S; Miyata T; Fujimura Y; Fujita T
Nephrol Dial Transplant; 2006 May; 21(5):1289-92. PubMed ID: 16449289
[TBL] [Abstract][Full Text] [Related]
9. Paradigm shift of childhood thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency.
Yagi H; Matsumoto M; Fujimura Y
Presse Med; 2012 Mar; 41(3 Pt 2):e137-55. PubMed ID: 22264931
[TBL] [Abstract][Full Text] [Related]
10. Inherited ADAMTS13 deficiency (Upshaw-Schulman syndrome): a short review.
Pérez-Rodríguez A; Lourés E; Rodríguez-Trillo Á; Costa-Pinto J; García-Rivero A; Batlle-López A; Batlle J; López-Fernández MF
Thromb Res; 2014 Dec; 134(6):1171-5. PubMed ID: 25242241
[TBL] [Abstract][Full Text] [Related]
11. Two novel heterozygote missense mutations of the ADAMTS13 gene in a child with recurrent thrombotic thrombocytopenic purpura.
Rossio R; Ferrari B; Cairo A; Mancini I; Pisapia G; Palazzo G; Peyvandi F
Blood Transfus; 2013 Apr; 11(2):241-4. PubMed ID: 23058857
[TBL] [Abstract][Full Text] [Related]
12. Highly elevated plasma level of von Willebrand factor accelerates the formation of platelet thrombus under high shear stress in plasma with deficient ADAMTS13 activity.
Yagi H; Yamaguchi N; Shida Y; Sugimoto M; Tubaki K; Fujimura Y; Matsumoto M
Thromb Res; 2017 Nov; 159():91-95. PubMed ID: 29040872
[TBL] [Abstract][Full Text] [Related]
13. Experiences in a family with the Upshaw-Schulman syndrome over a 44-year period.
Bennett M; Chubar Y; Gavish I; Aviv A; Stemer G; Chap-Marshak D
Clin Appl Thromb Hemost; 2014 Apr; 20(3):296-303. PubMed ID: 23872162
[TBL] [Abstract][Full Text] [Related]
14. Upshaw-Schulman syndrome-associated ADAMTS13 variants possess proteolytic activity at the surface of endothelial cells and in simulated circulation.
Letzer A; Lehmann K; Mess C; König G; Obser T; Peine S; Schneppenheim S; Budde U; Schneider SW; Schneppenheim R; Brehm MA
PLoS One; 2020; 15(5):e0232637. PubMed ID: 32365113
[TBL] [Abstract][Full Text] [Related]
15. Case of maternal and fetal deaths due to severe congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome) during pregnancy.
Tanaka H; Tenkumo C; Mori N; Kokame K; Fujimura Y; Hata T
J Obstet Gynaecol Res; 2014 Jan; 40(1):247-9. PubMed ID: 23937165
[TBL] [Abstract][Full Text] [Related]
16. Thrombotic thrombocytopenic purpura related to severe ADAMTS13 deficiency in children.
Loirat C; Girma JP; Desconclois C; Coppo P; Veyradier A
Pediatr Nephrol; 2009 Jan; 24(1):19-29. PubMed ID: 18574602
[TBL] [Abstract][Full Text] [Related]
17. Hereditary TTP/Upshaw-Schulman syndrome: the ductus arteriosus controls newborn survival.
Fujimura Y
Int J Hematol; 2024 May; 119(5):532-540. PubMed ID: 38536644
[TBL] [Abstract][Full Text] [Related]
18. Deficient activity of von Willebrand factor-cleaving protease in patients with Upshaw-Schulman syndrome.
Sasahara Y; Kumaki S; Ohashi Y; Minegishi M; Kano H; Bessho F; Tsuchiya S
Int J Hematol; 2001 Jul; 74(1):109-14. PubMed ID: 11530799
[TBL] [Abstract][Full Text] [Related]
19. [ADAMTS13, von Willebrand factor specific cleaving protease].
Veyradier A; Coppo P
Med Sci (Paris); 2011 Dec; 27(12):1097-105. PubMed ID: 22192749
[TBL] [Abstract][Full Text] [Related]
20. Natural history of Upshaw-Schulman syndrome based on ADAMTS13 gene analysis in Japan.
Fujimura Y; Matsumoto M; Isonishi A; Yagi H; Kokame K; Soejima K; Murata M; Miyata T
J Thromb Haemost; 2011 Jul; 9 Suppl 1():283-301. PubMed ID: 21781265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
